Heart Disease Journals

Cardiology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kirtane AJ et al. – Results of randomized controlled trials (RCTs) show no significant differences in long-term rates of death or myocardial infarction after drug-eluting (DES) or bare metal stent (BMS) use for either off- or on-label indications. In real-world nonrandomized observational studies with more pts but potential selection bias, DES use associated with reduced death and myocardial infarction. Both RCTs and observational studies showed marked and comparable reductions in target vessel revascularization with DES vs BMS.

Methods

Results